Investigative Concerns
• Biologist:
-Which treatments will elucidate the biological mechanism under investigation?
• Statistician:
-Existing machine learning techniques for microarray data analysis find broad expression pattern similarities, but we are interested in identifying specific perturbations of the network.
-A classic linear model is appropriate for the experimental design, but the notion of "baseline" has changed.
-Multivariate model? -Multiple testing?
• Both:
-High-throughput gene selection -Interpretation of results
Estrogen Target Experiment

Experimental question:
-Which genes are targets of estrogen (ES), and can we differentiate between primary and secondary targets?
• Target: gene affected at the mRNA level in the presence of ES • Primary target: gene that is directly activated or repressed at the mRNA transcript level by a mechanism that does not require the protein products of other ES-regulated genes, -e.g. A gene with an estrogen receptor element (ERE) in its promoter that is directly activated by ES-bound estrogen receptor α (ER).
• • Here we use univariate linear models since we do not yet fully understand the biological components that drive joint regulation.
• The estrogen targets that we identify using these models would be candidates for gene-at-a-time network perturbation models. 
Linear Model Parameters: Scenario 1
Outliers
We use the replicate structure of the experimental design to locate single outliers in the data set. The algorithm is based on differences between the replicate expression values that are larger than expected.
Outlier Detection Outlier Detection
• This method only identifies pairs with large differences, not the single outlier itself.
• Once pairs are identified, we designate single outliers if one of the tagged replicates falls outside the range • Since we will form linear models and apply a test of contrast to tens of thousands of genes, we need to adjust for multiple testing.
• We use the False Discovery Rate (FDR) method of Benjamini and Hochberg (1995).
-Tends to give longer lists of genes.
-Since a rejected hypothesis indicates an ES target in our application, we can interpret the FDR as the proportion of falsely identified ES targets.
1. Average the replicate observations and exclude any genes with a maximum average less than 100 (using the PM-only model for gene expression in dChip). Remove all Affymetrix control sequences 2. Apply any necessary transformations to satisfy Normality, then test for single outliers. If outliers are identified, remove them from the data set.
3. Fit the linear model for each gene. • Treated ZR75-1 breast cancer cells with CX and ES or CX and one of three antiestrogens (tamoxifen, raloxifen, faslodex).
• Selected primary estrogen targets by examining fold change ratios under antiestrogen/CX and ES/CX conditions. 
